0001493152-21-015884.txt : 20210701 0001493152-21-015884.hdr.sgml : 20210701 20210701182159 ACCESSION NUMBER: 0001493152-21-015884 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210701 FILED AS OF DATE: 20210701 DATE AS OF CHANGE: 20210701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KINGSLEY ALFRED D CENTRAL INDEX KEY: 0001229339 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12830 FILM NUMBER: 211067361 MAIL ADDRESS: STREET 1: 150 E 57TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lineage Cell Therapeutics, Inc. CENTRAL INDEX KEY: 0000876343 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943127919 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2173 SALK AVENUE STREET 2: SUITE 200 CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 5105213390 MAIL ADDRESS: STREET 1: 2173 SALK AVENUE STREET 2: SUITE 200 CITY: CARLSBAD STATE: CA ZIP: 92008 FORMER COMPANY: FORMER CONFORMED NAME: BIOTIME INC DATE OF NAME CHANGE: 19930328 4 1 ownership.xml X0306 4 2021-07-01 0 0000876343 Lineage Cell Therapeutics, Inc. LCTX 0001229339 KINGSLEY ALFRED D C/O LINEAGE CELL THERAPEUTICS 2173 SALK AVENUE, SUITE 200 CARLSBAD CA 92008 1 0 0 0 Stock Option (right to buy) 2.86 2021-07-01 4 A 0 80000 0 A 2031-07-01 Common Shares 80000 80000 D Will vest and become exercisable on July 1, 2022, subject to the reporting person's continuous service with the issuer. /s/ Grant Harbert, as Attorney-in-Fact 2021-07-01